CoronaVac (Malay Wikipedia)

Analysis of information sources in references of the Wikipedia article "CoronaVac" in Malay language version.

refsWebsite

Global rank Malay rank

2clinicaltrials.gov

5,225^th place

low place

2reuters.com

49^th place

98^th place

1jakartaglobe.id

low place

2,266^th place

1ina-registry.org

low place

1scmp.com

362^nd place

215^th place

1bloomberg.com

99^th place

160^th place

1channelnewsasia.com

1,127^th place

81^st place

1thelancet.com

2,393^rd place

4,033^rd place

1doi.org

2^nd place

8^th place

1worldcat.org

5^th place

23^rd place

1nih.gov

4^th place

14^th place

1semanticscholar.org

11^th place

67^th place

1alkhaleejtoday.co

low place

alkhaleejtoday.co

"CoronaVac: Doses will come from China on nine flights and can..." AlKhaleej Today (dalam bahasa Inggeris). 1 November 2020. Dicapai pada 1 November 2020.

bloomberg.com

"Brazil Clears Sinovac Trial to Resume Two Days After Halting It". Bloomberg.com (dalam bahasa Inggeris). 11 November 2020. Dicapai pada 11 November 2020.

channelnewsasia.com

"Indonesia receives first COVID-19 vaccine from China's Sinovac". CNA (dalam bahasa Inggeris). Dicapai pada 6 Disember 2020.

clinicaltrials.gov

Ujian klinikal bernombor NCT04456595 bagi "Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)" di ClinicalTrials.gov
Ujian klinikal bernombor NCT04551547 bagi "A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine (Vero Cell) in Healthy Population Aged 3-17 Years" di ClinicalTrials.gov

doi.org

Zhang, Yanjun; Zeng, Gang; Pan, Hongxing; Li, Changgui; Hu, Yaling; Chu, Kai; Han, Weixiao; Chen, Zhen; Tang, Rong; Yin, Weidong; Chen, Xin (17 November 2020). "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial". The Lancet Infectious Diseases (dalam bahasa Inggeris). 0. doi:10.1016/S1473-3099(20)30843-4. ISSN 1473-3099. PMID 33217362. S2CID 227099817.

ina-registry.org

"A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18-59 years in Indonesia". PT Bio Farma (dalam bahasa Inggeris). Registri Penyakit Indonesia. 10 Ogos 2020. Dicapai pada 15 Ogos 2020.

jakartaglobe.id

Beritasatu, Shofa JN (11 August 2020). "Indonesia Starts CoronaVac Phase 3 Clinical Trials". Jakarta Globe (dalam bahasa Inggeris). Dicapai pada 26 Ogos 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Zhang, Yanjun; Zeng, Gang; Pan, Hongxing; Li, Changgui; Hu, Yaling; Chu, Kai; Han, Weixiao; Chen, Zhen; Tang, Rong; Yin, Weidong; Chen, Xin (17 November 2020). "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial". The Lancet Infectious Diseases (dalam bahasa Inggeris). 0. doi:10.1016/S1473-3099(20)30843-4. ISSN 1473-3099. PMID 33217362. S2CID 227099817.

reuters.com

Staff, Reuters (3 Disember 2020). "Sao Paulo state gets 1 million doses of China candidate vaccine". Reuters (dalam bahasa Inggeris). Dicapai pada 3 Disember 2020.
Staff (7 September 2020). "China's Sinovac coronavirus vaccine candidate appears safe, slightly weaker in elderly". Reuters (dalam bahasa Inggeris). Dicapai pada 6 Oktober 2020.

scmp.com

"Tests show China's Sinovac vaccine is safe, Brazil research centre says". South China Morning Post (dalam bahasa Inggeris). 2020-10-20. Dicapai pada 19 Oktober 2020.

semanticscholar.org

api.semanticscholar.org

Zhang, Yanjun; Zeng, Gang; Pan, Hongxing; Li, Changgui; Hu, Yaling; Chu, Kai; Han, Weixiao; Chen, Zhen; Tang, Rong; Yin, Weidong; Chen, Xin (17 November 2020). "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial". The Lancet Infectious Diseases (dalam bahasa Inggeris). 0. doi:10.1016/S1473-3099(20)30843-4. ISSN 1473-3099. PMID 33217362. S2CID 227099817.

thelancet.com

Zhang, Yanjun; Zeng, Gang; Pan, Hongxing; Li, Changgui; Hu, Yaling; Chu, Kai; Han, Weixiao; Chen, Zhen; Tang, Rong; Yin, Weidong; Chen, Xin (17 November 2020). "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial". The Lancet Infectious Diseases (dalam bahasa Inggeris). 0. doi:10.1016/S1473-3099(20)30843-4. ISSN 1473-3099. PMID 33217362. S2CID 227099817.

worldcat.org

Zhang, Yanjun; Zeng, Gang; Pan, Hongxing; Li, Changgui; Hu, Yaling; Chu, Kai; Han, Weixiao; Chen, Zhen; Tang, Rong; Yin, Weidong; Chen, Xin (17 November 2020). "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial". The Lancet Infectious Diseases (dalam bahasa Inggeris). 0. doi:10.1016/S1473-3099(20)30843-4. ISSN 1473-3099. PMID 33217362. S2CID 227099817.